hexamethonium has been researched along with vasoactive intestinal peptide, 4-chloro-phe(6)-leu(17)- in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giralt, M; Vergara, P | 1 |
| Bianciotti, LG; Corbo, NS; Rodríguez, MR; Sabbatini, ME; Vatta, MS | 1 |
| Bornstein, JC; Larsson, MH; Lindström, E; Sapnara, M; Sjövall, H; Svensson, DJ; Thomas, EA | 1 |
| Lu, YX; Owyang, C; Zhou, SY | 1 |
4 other study(ies) available for hexamethonium and vasoactive intestinal peptide, 4-chloro-phe(6)-leu(17)-
| Article | Year |
|---|---|
Inhibition by CCK of ascending contraction elicited by mucosal stimulation in the duodenum of the rat.
Topics: Adrenergic beta-Antagonists; Animals; Atropine; Benzodiazepinones; Cholecystokinin; Depression, Chemical; Devazepide; Duodenum; Electric Stimulation; Enteric Nervous System; Enzyme Inhibitors; Gastrins; Hexamethonium; Intestinal Mucosa; Male; Muscle Contraction; Nicotinic Antagonists; Nitroarginine; Oligopeptides; Parasympatholytics; Peristalsis; Phentolamine; Phenylurea Compounds; Propranolol; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Receptors, Vasoactive Intestinal Peptide; Sincalide; Tetragastrin; Vasoactive Intestinal Peptide | 2000 |
C-type natriuretic peptide applied to the brain enhances exocrine pancreatic secretion through a vagal pathway.
Topics: Animals; Atrial Natriuretic Factor; Atropine; Brain; Cyclic GMP; Drug Interactions; Enzyme Inhibitors; Ganglionic Blockers; Hexamethonium; Natriuretic Peptide, C-Type; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pancreas; Parasympatholytics; Peptide Fragments; Proteins; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor; Secretin; Sincalide; Thionucleotides; Time Factors; Vagotomy; Vagus Nerve; Vasoactive Intestinal Peptide | 2005 |
Pharmacological analysis of components of the change in transmural potential difference evoked by distension of rat proximal small intestine in vivo.
Topics: Anesthetics, Local; Animals; Atropine; Chlorides; Colon; Duodenum; Enzyme Inhibitors; Ganglionic Blockers; Granisetron; Hexamethonium; Hormone Antagonists; Injections, Intravenous; Intestinal Secretions; Lidocaine; Male; Mechanotransduction, Cellular; Membrane Potentials; Mice; Mice, Inbred C57BL; Muscarinic Antagonists; Neurokinin-1 Receptor Antagonists; Nitric Oxide Synthase; Nitroarginine; Peripheral Nervous System Agents; Piperidines; Pressure; Quinolines; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Receptors, Neurokinin-3; Receptors, Serotonin, 5-HT3; Receptors, Vasoactive Intestinal Peptide; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Tetrodotoxin; Time Factors; Vasoactive Intestinal Peptide | 2008 |
Gastric relaxation induced by hyperglycemia is mediated by vagal afferent pathways in the rat.
Topics: Afferent Pathways; Animals; Blood Glucose; Capsaicin; Carbachol; Electric Stimulation; Fenclonine; Gastrointestinal Motility; Glucose; Granisetron; Hexamethonium; Hormone Antagonists; Hyperglycemia; Male; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Pressure; Rats; Rats, Sprague-Dawley; Stomach; Vagotomy; Vagus Nerve; Vasoactive Intestinal Peptide | 2008 |